Cargando…

Multiple primary malignancies involving lung cancer

BACKGROUND: The incidence of multiple primary malignancies (MPM) has increased sharply in recent decades. However, the clinical characteristics and prognosis of MPM patients involving lung cancer were not fully elucidated. This retrospective study was designed to explore the clinical characteristics...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Feng, Zhong, Wen-Zhao, Niu, Fei-Yu, Zhao, Ning, Yang, Jin-Ji, Yan, Hong-Hong, Wu, Yi-Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606552/
https://www.ncbi.nlm.nih.gov/pubmed/26466785
http://dx.doi.org/10.1186/s12885-015-1733-8
_version_ 1782395371743346688
author Li, Feng
Zhong, Wen-Zhao
Niu, Fei-Yu
Zhao, Ning
Yang, Jin-Ji
Yan, Hong-Hong
Wu, Yi-Long
author_facet Li, Feng
Zhong, Wen-Zhao
Niu, Fei-Yu
Zhao, Ning
Yang, Jin-Ji
Yan, Hong-Hong
Wu, Yi-Long
author_sort Li, Feng
collection PubMed
description BACKGROUND: The incidence of multiple primary malignancies (MPM) has increased sharply in recent decades. However, the clinical characteristics and prognosis of MPM patients involving lung cancer were not fully elucidated. This retrospective study was designed to explore the clinical characteristics and prognosis of MPM patients involving lung cancer in the People’s Republic of China. METHODS: Of 5405 lung cancer cases diagnosed at the Guangdong Lung Cancer Institute between 2005 and 2013, we analyzed 185 patients (3.4 %) with MPM involving lung cancer. RESULTS: Among 185 patients with MPM involving lung cancer, 10 (5.4 %)had three malignancies and 175 (94.6 %) had two malignancies. 10 patients with three malignancies were excluded from the analysis to avoid misunderstanding. Of 175 accompanying malignancies, 64 (36.6 %) were synchronous MPM patients and 111 (63.4 %) were metachronous MPM patients; 49 (28.0 %) were lung cancer first MPM patients and 126 (72.0 %) were other cancer first MPM patients. The most frequent accompanying malignancy was colon cancer (25/175), followed by rectal cancer (18/175), esophageal cancer (17/175), and thyroid cancer (13/175). Metachronous MPM patients showed significantly better overall survival (OS) than synchronous MPM, with a median OS of 72.8 (range 12.2–391.0) and 12.9 (range 0.8–86.3)months, respectively (P < 0.001). Cox regression analysis revealed that time of occurrence and stage were independent factors for OS. CONCLUSIONS: Colorectal cancer, esophageal cancer, and thyroid cancer were the tumors that most frequently accompanying lung cancer. Metachronous MPM patients showed significantly better OS compared with synchronous MPM patients.
format Online
Article
Text
id pubmed-4606552
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46065522015-10-16 Multiple primary malignancies involving lung cancer Li, Feng Zhong, Wen-Zhao Niu, Fei-Yu Zhao, Ning Yang, Jin-Ji Yan, Hong-Hong Wu, Yi-Long BMC Cancer Research Article BACKGROUND: The incidence of multiple primary malignancies (MPM) has increased sharply in recent decades. However, the clinical characteristics and prognosis of MPM patients involving lung cancer were not fully elucidated. This retrospective study was designed to explore the clinical characteristics and prognosis of MPM patients involving lung cancer in the People’s Republic of China. METHODS: Of 5405 lung cancer cases diagnosed at the Guangdong Lung Cancer Institute between 2005 and 2013, we analyzed 185 patients (3.4 %) with MPM involving lung cancer. RESULTS: Among 185 patients with MPM involving lung cancer, 10 (5.4 %)had three malignancies and 175 (94.6 %) had two malignancies. 10 patients with three malignancies were excluded from the analysis to avoid misunderstanding. Of 175 accompanying malignancies, 64 (36.6 %) were synchronous MPM patients and 111 (63.4 %) were metachronous MPM patients; 49 (28.0 %) were lung cancer first MPM patients and 126 (72.0 %) were other cancer first MPM patients. The most frequent accompanying malignancy was colon cancer (25/175), followed by rectal cancer (18/175), esophageal cancer (17/175), and thyroid cancer (13/175). Metachronous MPM patients showed significantly better overall survival (OS) than synchronous MPM, with a median OS of 72.8 (range 12.2–391.0) and 12.9 (range 0.8–86.3)months, respectively (P < 0.001). Cox regression analysis revealed that time of occurrence and stage were independent factors for OS. CONCLUSIONS: Colorectal cancer, esophageal cancer, and thyroid cancer were the tumors that most frequently accompanying lung cancer. Metachronous MPM patients showed significantly better OS compared with synchronous MPM patients. BioMed Central 2015-10-14 /pmc/articles/PMC4606552/ /pubmed/26466785 http://dx.doi.org/10.1186/s12885-015-1733-8 Text en © Li et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Li, Feng
Zhong, Wen-Zhao
Niu, Fei-Yu
Zhao, Ning
Yang, Jin-Ji
Yan, Hong-Hong
Wu, Yi-Long
Multiple primary malignancies involving lung cancer
title Multiple primary malignancies involving lung cancer
title_full Multiple primary malignancies involving lung cancer
title_fullStr Multiple primary malignancies involving lung cancer
title_full_unstemmed Multiple primary malignancies involving lung cancer
title_short Multiple primary malignancies involving lung cancer
title_sort multiple primary malignancies involving lung cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606552/
https://www.ncbi.nlm.nih.gov/pubmed/26466785
http://dx.doi.org/10.1186/s12885-015-1733-8
work_keys_str_mv AT lifeng multipleprimarymalignanciesinvolvinglungcancer
AT zhongwenzhao multipleprimarymalignanciesinvolvinglungcancer
AT niufeiyu multipleprimarymalignanciesinvolvinglungcancer
AT zhaoning multipleprimarymalignanciesinvolvinglungcancer
AT yangjinji multipleprimarymalignanciesinvolvinglungcancer
AT yanhonghong multipleprimarymalignanciesinvolvinglungcancer
AT wuyilong multipleprimarymalignanciesinvolvinglungcancer